Non-interventional Study Describing Healthcare Resource Utilisation and Clinical Outcomes Associated With VNS Therapy in UK.
← catalyst calendarSponsored by LivaNova (industry) · LIVN — their whole pipeline →. With OPEN VIE Limited.
Phase
—
Status
Terminated
Study type
Observational
Enrollment
97actual
Sites
5
Country
United Kingdom
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Why the sponsor stopped it
The study was terminated by the sponsor due to persistent delays in recruitment and data availability, including access to the healthcare resource utilization database, which made it difficult to generate meaningful outcomes.
As filed on the registry record, in the sponsor's own words.
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2021-05-11 | actual | When the study began enrolling |
| Primary completion | 2025-08-19 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-08-19 | actual | The whole study's end, after follow-up |
| First posted | 2021-03-03 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-03-25 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Epilepsy
Primary outcome
what the primary-completion date above is the date OFChange in hospital resource utilization
measured 12-month pre- implantation of VNS device to 18-month post-implantation of VNS device
Permalink · LIVN's whole pipeline · Catalyst calendar · Every registered study · What changed